Invesaro

Stocks TJX Financial statements

Financial statements

TJX COMPANIES INC /DE/ financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data TJX COMPANIES INC /DE/ files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2016FY2017FY2018FY2019FY2020FY2022FY2023FY2024FY2025FY2026
Revenue33,18435,86538,97341,71732,13748,55049,93654,21756,36060,372
Cost of revenue23,56625,50227,83129,84624,53434,71436,14937,95139,11241,679
Gross profit9,61810,36211,14211,8717,60313,83613,78716,26617,24818,693
Selling, general and administrative5,7686,3756,9247,4557,0219,0818,92710,46910,94611,515
Operating income4,2584,4034,763
Interest expense69.269.269.161.419912391827879
Interest income18.132.75649.113478249257195
Pre-tax income3,7233,8574,1734,406894,3984,6365,9676,4837,299
Income tax1,4251,2491,1131,134-11,1151,1381,4931,6191,805
Net income2,2982,6083,0603,272903,2833,4984,4744,8645,494
EBITDA4,9175,1295,583
EPS, basic1.752.052.472.710.082.743.003.904.314.93
EPS, diluted1.732.022.432.670.072.702.973.864.264.87
Shares, basic (weighted)1,3111,2741,2411,2081,2001,2001,1661,1461,1281,114
Shares, diluted (weighted)1,3291,2921,2591,2271,2151,2161,1781,1591,1421,128
Dividend per share0.520.630.780.920.261.041.181.331.501.70

Balance sheet

FY2016FY2017FY2018FY2019FY2020FY2022FY2023FY2024FY2025FY2026
Cash and equivalents2,9302,7583,0303,21710,4706,2275,4775,6005,3356,230
Short-term investments5435060
Receivables259327346386461518563529549602
Inventory3,6454,1874,5794,8734,3375,9625,8195,9656,4217,297
Other current assets3747075143684354374785116171,065
Total current assets7,7518,4868,4698,89115,73913,25912,45612,66412,99115,202
Property, plant and equipment4,5335,0065,2555,3255,0365,2715,7836,5717,3468,220
Lease right-of-use assets9,0608,9908,8549,0869,3969,64110,330
Goodwill19610097.695.5999797959496
Other non-current assets3984604987618227957698491,5291,772
Total assets12,88414,05814,32624,14530,81428,46128,34929,74731,74935,767
Accounts payable2,2312,4882,6442,6734,8234,4653,7943,8624,2574,575
Accrued liabilities6306867388199461,1179681,3991,3701,727
Short-term debt0750050000999
Total current liabilities4,7585,1265,5317,15010,80410,46810,30510,45111,00813,361
Long-term debt2,2282,2312,2342,2375,3333,3552,8592,8622,8661,870
Lease liabilities7,8177,7437,5767,7758,0608,2768,894
Other non-current liabilities1,0741,3211,3548511,0641,0159199241,0501,184
Total liabilities8,3738,9109,27718,19724,98122,45821,98522,44523,35625,577
Total debt2,2282,2312,2342,2376,0833,3553,3592,8622,8662,869
Paid-in capital000026100000
Retained earnings4,5594,3344,4625,4224,9745,5095,8156,7007,8839,434
Other comprehensive income-694-442-630-673-606-687-606-532-609-351
Shareholders' equity4,5115,1485,0495,9485,8336,0036,3647,3028,39310,190
Total equity4,5115,1485,0495,9485,8336,0036,3647,3028,39310,190
Total liabilities and equity12,88414,05814,32624,14530,81428,46128,34929,74731,74935,767
Shares outstanding6461,2561,2171,1991,2051,1811,1551,1341,1191,107

Cash flow statement

FY2016FY2017FY2018FY2019FY2020FY2022FY2023FY2024FY2025FY2026
Net income2,2982,6083,0603,272903,2833,4984,4744,8645,494
Depreciation and amortization6597268208678718688879641,1041,247
Stock-based compensation10210110412559189122160183214
Deferred income tax-5.5-137-88.6-6.23-231-4464-728112
Change in receivables-23.2-62.4-23.5-43-71-61-5137-26-41
Change in inventory11.9-450-465-297589-1,65858-145-539-724
Change in payables48.320519829.32,111-338-60064448239
Cash from operations3,6273,0264,0884,0674,5623,0574,0846,0576,1166,874
Capital expenditures-1,025-1,058-1,125-1,223-568-1,045-1,457-1,722-1,918-1,957
Acquisitions-2.32
Purchases of investments-717-861-162-28.8-29-22-31-28-35-38
Cash from investing-1,215-1,013-624-1,462-579-1,046-1,470-1,717-2,477-1,981
Debt issued9930005,98700
Debt repaid-2,9760-50000
Stock issued164134255232211229321285366311
Share buybacks-1,700-1,645-2,407-1,552-202-2,176-2,255-2,484-2,513-2,522
Dividends paid-651-764-923-1,072-278-1,252-1,339-1,484-1,648-1,842
Cash from financing-1,587-2,297-3,097-2,4153,228-6,200-3,306-4,215-3,838-4,118
Exchange rate effect9.27113-95.7-3.1842-54-58-2-66120
Net change in cash834-1712721877,253-4,243-750123-265895
Free cash flow2,6021,9682,9632,8433,9942,0122,6274,3354,1984,917
Interest paid72.664.36456.315313986807474
Income taxes paid1,2821,2901,1481,2811461,1191,2251,4321,6321,471

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to August 1, 2026; growth uses fiscal years. Valuation uses the share price of $130.06 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Gross margin32.0%Gross profit / revenue.
Pre-tax margin12.9%Pre-tax income / revenue.
Net margin9.7%Net income / revenue.
FCF margin9.4%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin12.9%Cash from operations / revenue.
Effective tax rate24.6%Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)57.0%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)16.3%Net income / average total assets.
SG&A / revenue19.3%Selling, general and administrative expense / revenue.
Stock-based pay / revenue0.4%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue3.5%Capital expenditures / revenue.
D&A / revenue2.1%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y7.1%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y6.5%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y13.4%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y8.4%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y10.7%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y19.7%Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y13.0%Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y16.2%Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y127.6%Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y14.3%EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y17.9%Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y133.6%Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y12.4%Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y19.0%Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y8.5%Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y17.1%Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y23.2%Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y4.2%Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y13.3%Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y12.9%Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y45.6%Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y21.4%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y17.0%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y11.8%Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y12.7%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y8.1%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y3.0%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y-1.2%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y-1.4%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y-1.5%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio1.15xCurrent assets / current liabilities.
Quick ratio0.50x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio0.45x(Cash + short-term investments) / current liabilities.
Debt / equity0.27xTotal debt / shareholders' equity. Not shown when equity is negative.
Debt / assets7.7%Total debt / total assets.
Liabilities / assets71.3%Total liabilities / total assets.
Net debt-$3.13BTotal debt - cash - short-term investments. Negative means more cash than debt.
Working capital$1.97BCurrent assets - current liabilities.
Goodwill and intangibles / assets0.3%(Goodwill + intangible assets) / total assets.
Tangible book value$10.55BShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover1.68xRevenue / average total assets.
Fixed asset turnover7.28xRevenue / average property, plant and equipment.
Inventory turnover5.39xCost of revenue / average inventory.
Days inventory68 days365 x average inventory / cost of revenue.
Receivables turnover93.8xRevenue / average receivables.
Days sales outstanding4 days365 x average receivables / revenue.
Days payables43 days365 x average accounts payable / cost of revenue.
Cash conversion cycle28 daysDays inventory + days sales outstanding - days payables.
FCF conversion96.9%Free cash flow / net income, when net income is positive.
Capex / operating cash flow26.9%Capital expenditures / cash from operations, when that is positive.

Per share

MetricValueHow it is calculated
EPS, diluted$5.43Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share$55.83Revenue / diluted weighted shares.
FCF per share$5.26Free cash flow / diluted weighted shares.
Operating cash flow per share$7.19Cash from operations / diluted weighted shares.
Book value per share$9.67Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share$9.58Tangible book value / shares outstanding.
Cash per share$5.45(Cash + short-term investments) / shares outstanding.
Payout ratio32.1%Dividends paid / net income, when net income is positive.
Dividends / FCF33.2%Dividends paid / free cash flow, when free cash flow is positive.
Buybacks / FCF47.6%Share buybacks / free cash flow, when free cash flow is positive.

Valuation

MetricValueHow it is calculated
Market cap$143.68BShare price x shares outstanding.
Enterprise value$140.54BMarket cap + total debt - cash - short-term investments.
P/E23.7xMarket cap / net income. Only when net income is positive.
P/S2.30xMarket cap / revenue.
P/B13.5xMarket cap / shareholders' equity. Only when equity is positive.
Price / tangible book13.6xMarket cap / tangible book value, when positive.
P/FCF24.5xMarket cap / free cash flow. Only when free cash flow is positive.
P/OCF17.9xMarket cap / cash from operations, when positive.
EV/Sales2.25xEnterprise value / revenue.
EV/FCF23.9xEnterprise value / free cash flow, when both are positive.
FCF yield4.1%Free cash flow / market cap.
Earnings yield4.2%Net income / market cap (the inverse of P/E).
Dividend yield1.4%Dividends paid over the period / market cap.
Shareholder yield3.3%(Dividends paid + share buybacks) / market cap.
PEG1.32xP/E / EPS growth per year over 3 years (in percent). Only when both are positive.
What was TJX COMPANIES INC /DE/'s revenue in fiscal 2026?

TJX COMPANIES INC /DE/ reported revenue of $60.37B for fiscal 2026, 7.1% higher than the year before.

Was TJX COMPANIES INC /DE/ profitable in fiscal 2026?

Yes. Net income was $5.49B, a net margin of 9.1%.

How much free cash flow did TJX COMPANIES INC /DE/ generate in fiscal 2026?

Cash from operations of $6.87B minus capital expenditures of $1.96B left free cash flow of $4.92B.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to TJX COMPANIES INC /DE/